These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 16775018)

  • 1. Uncertainty and 'technological horizon' in qualitative interviews about HIV treatment.
    Davis M; Frankis J; Flowers P
    Health (London); 2006 Jul; 10(3):323-44. PubMed ID: 16775018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV generations? Generational discourse in interviews with Australian general practitioners and their HIV positive gay male patients.
    Newman C; Mao L; Canavan PG; Kidd MR; Saltman DC; Kippax SC
    Soc Sci Med; 2010 Jun; 70(11):1721-7. PubMed ID: 20347197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions of HAART among gay men who declined a treatment offer: preliminary results from an interview-based study.
    Cooper V; Buick D; Horne R; Lambert N; Gellaitry G; Leake H; Fisher M
    AIDS Care; 2002 Jun; 14(3):319-28. PubMed ID: 12042077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis over time (1990-2000) of the experiences of living with HIV.
    Pierret J
    Soc Sci Med; 2007 Oct; 65(8):1595-605. PubMed ID: 17683838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral treatment adherence and its correlates in Addis Ababa, Ethiopia.
    Tadios Y; Davey G
    Ethiop Med J; 2006 Jul; 44(3):237-44. PubMed ID: 17447389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus-associated prostate cancer: clinicopathological findings and outcome in a multi-institutional study.
    Pantanowitz L; Bohac G; Cooley TP; Aboulafia D; Dezube BJ
    BJU Int; 2008 Jun; 101(12):1519-23. PubMed ID: 18384640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over fifty and living with HIV in London.
    Elford J; Ibrahim F; Bukutu C; Anderson J
    Sex Transm Infect; 2008 Nov; 84(6):468-72. PubMed ID: 19028949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridging the gap between antiretroviral access and adherence in Mexico.
    Campero L; Herrera C; Kendall T; Caballero M
    Qual Health Res; 2007 May; 17(5):599-611. PubMed ID: 17478643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative assessment of decisions affecting contraceptive utilization and fertility intentions among HIV-positive women in Soweto, South Africa.
    Laher F; Todd CS; Stibich MA; Phofa R; Behane X; Mohapi L; Gray G
    AIDS Behav; 2009 Jun; 13 Suppl 1():47-54. PubMed ID: 19308719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When to initiate highly active antiretroviral therapy in low-resource settings: the Moroccan experience.
    Loubiere S; el Filal KM; Sodqi M; Loundou A; Luchini S; Cleary S; Moatti JP; Himmich H
    Antivir Ther; 2008; 13(2):241-51. PubMed ID: 18505175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical promise and the recalibration of expectation: hope and HIV treatment engagement in a transitional setting.
    Rhodes T; Bernays S; Terzić KJ
    Soc Sci Med; 2009 Mar; 68(6):1050-9. PubMed ID: 19167803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy.
    Riddler SA; Li X; Chu H; Kingsley LA; Dobs A; Evans R; Palella F; Visscher B; Chmiel JS; Sharrett A
    HIV Med; 2007 Jul; 8(5):280-7. PubMed ID: 17561873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "I will start treatment when I think the time is right": HIV-positive gay men talk about their decision not to access antiretroviral therapy.
    Gold RS; Ridge DT
    AIDS Care; 2001 Dec; 13(6):693-708. PubMed ID: 11720640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year adherence to clinic visits after highly active antiretroviral therapy: a predictor of clinical progress in HIV patients.
    Park WB; Choe PG; Kim SH; Jo JH; Bang JH; Kim HB; Kim NJ; Oh M; Choe KW
    J Intern Med; 2007 Mar; 261(3):268-75. PubMed ID: 17305649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
    Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
    Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cultural diversity teaching and issues of uncertainty: the findings of a qualitative study.
    Dogra N; Giordano J; France N
    BMC Med Educ; 2007 Apr; 7():8. PubMed ID: 17462089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous response to HAART across a diverse population of people living with HIV: results from the ANRS-EN12-VESPA Study.
    Dray-Spira R; Spire B; Heard I; Lert F;
    AIDS; 2007 Jan; 21 Suppl 1():S5-12. PubMed ID: 17159588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs and benefits of HAART for patients with HIV in a public hospital in Mexico.
    Aracena-Genao B; Navarro JO; Lamadrid-Figueroa H; Forsythe S; Trejo-Valdivia B
    AIDS; 2008 Jul; 22 Suppl 1():S141-8. PubMed ID: 18664946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
    Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
    Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
    Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
    Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.